The Pharmacokinetics of Sildenafil May Be Affected by Intestinal Absorption Rate in Children Admitted to the Intensive Care Unit

DOI Web Site Web Site PubMed 14 References Open Access
  • Oya Yukino
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
  • Watahiki Daisuke
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
  • Matsunaga Mitsuki
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
  • Hirono Keiichi
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
  • Ichida Fukiko
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
  • Aoki Masaya
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
  • Yoshimura Naoki
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
  • Taguchi Masato
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

Search this article

Abstract

<p>This study was performed for a better understanding of the pharmacokinetics of sildenafil (SIL) and N-desmethyl sildenafil (DMS) in 13 children treated in the intensive care unit (ICU). Blood samples were taken periodically after the first oral administration of SIL (0.5 mg/kg). Plasma concentrations were analyzed by tandem LC/MS. Of the 13 patients, apparent peaks in the plasma concentration of SIL were observed in four patients, with the other nine patients showing reduced or delayed drug absorption of SIL. The maximum plasma concentrations of SIL after administration varied in range from 7.8 to 101.0 ng/mL. The parent drug-to-metabolite (SIL/DMS) ratios of the nine patients with reduced or delayed drug absorption of SIL were relatively lower than those in the four patients with rapid absorption of the drug. These observations suggested that the inter-individual variability of intestinal absorption and/or first-pass extraction of SIL was involved in the pharmacokinetic variability of the drug. Next, we evaluated the impact of changes in the gastrointestinal absorption rate on the pharmacokinetics of the drug. That is, SIL (2.5 mg/body) was administered at two different rates in the duodenum of rats. When SIL was administered for 10 min, the Cmax and bioavailability were 3.46 ± 1.65 µg/mL and 23.2 ± 11.1%, respectively. When SIL was administered for 60 min, the Cmax and bioavailability were 0.990 ± 0.352 µg/mL and 9.91 ± 3.79%, respectively. These findings suggest that the drug absorption rate was at least partly responsible for the pharmacokinetic variability of SIL in the ICU children.</p>

Journal

References(14)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top